A549 and H1299 lung cancer cells were treated with vehicle, HKLM (an agonist of TLR2), or poly(I:C) (an agonist of TLR3) in the presence or absence of propionate (an agonist of FFAR2), and the cell migration assay was performed. Here, TLR3 is linked to lung carcinoma.